Roche Launches Dual Antigen and Antibody Diagnostic Test for Hepatitis C

Health News

ZURICH (Reuters) – Roche has launched a new dual antigen and antibody diagnostic test for hepatitis C, the Swiss pharmaceuticals company said on Monday, which it says will give an earlier diagnosis of the virus.

The Elecsys HCV Duo is the first commercially available immunoassay that allows the simultaneous and independent determination of the hepatitis C virus status from a single human plasma or serum sample.

In 2019, 58 million people in the world were living with chronic hepatitis C infection, but only 21% were aware of it, according to World Health Organization data. The disease can lead to death from conditions including cirrhosis and liver failure.

(Reporting by John Revill; Editing by Kim Coghill)

Source: Read Full Article

Related posts:
  1. Covid vaccine: What is the Sinovac vaccine? How effective is China’s coronavirus vaccine?
  2. Miniaturized models of neuron-muscle interactions give insight in ALS
  3. Researchers find that combining melatonin with vancomycin reduces kidney failure
  4. Statins side effects: ‘Pink-red blotches’ considered serious side effect – ‘call a doctor’
  5. Struggling to calm anxiety before bed? Here’s how ‘vagus nerve icing’ could help